Taisho Pharmaceutical Holdings Stock Cash Flow From Operations
Taisho Pharmaceutical Holdings fundamentals help investors to digest information that contributes to Taisho Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Taisho Pink Sheet. The fundamental analysis module provides a way to measure Taisho Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Taisho Pharmaceutical pink sheet.
Taisho |
Taisho Pharmaceutical Holdings Company Cash Flow From Operations Analysis
Taisho Pharmaceutical's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Taisho Pharmaceutical Cash Flow From Operations | 28.51 B |
Most of Taisho Pharmaceutical's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Taisho Pharmaceutical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Taisho Pharmaceutical Holdings has 28.51 B in Cash Flow From Operations. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The cash flow from operations for all United States stocks is significantly lower than that of the firm.
Taisho Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Taisho Pharmaceutical's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Taisho Pharmaceutical could also be used in its relative valuation, which is a method of valuing Taisho Pharmaceutical by comparing valuation metrics of similar companies.Taisho Pharmaceutical is currently under evaluation in cash flow from operations category among its peers.
Taisho Fundamentals
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 327.94 M | |||
| Price To Earning | 20.67 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 268.2 B | |||
| Gross Profit | 163.83 B | |||
| EBITDA | 42.81 B | |||
| Net Income | 13.12 B | |||
| Cash And Equivalents | 276.54 B | |||
| Cash Per Share | 843.28 X | |||
| Current Ratio | 6.21 X | |||
| Book Value Per Share | 2,413 X | |||
| Cash Flow From Operations | 28.51 B | |||
| Earnings Per Share | 0.49 X | |||
| Number Of Employees | 9.13 K | |||
| Beta | 0.26 | |||
| Market Capitalization | 3.35 B | |||
| Total Asset | 888.16 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 888.16 B | |||
| Last Dividend Paid | 50.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |